Search
斯隆凯特琳研究所的研究人员的新发现，为深入了解一种被称为上皮-间质转化的基本生物学过程提供了重要思路。斯隆凯特琳研究所的研究人员的新发现，为深入了解一种被称为上皮-间质转化的基本生物学过程提供了重要思路。
Learn how immunotherapy holds promise for transforming the treatment of gynecologic cancers.
A family of drugs developed at MSK targets disrupted processes in cells in diseases related to aging.
Advances in diagnostic and imaging modalities are making it possible to detect complex melanoma earlier, with greater accuracy, and are helping guide surgical approaches and patient monitoring plans.
Three emerging investigators are tackling the mysteries of biology and cancer at Memorial Sloan Kettering.
The DNA breaks that occur during meiosis are necessary but dangerous. Scientists now have a better handle on how cells control the chaos.
Meet Ruben Escobar, an MSK security guard who values his family members, friends, and colleagues who have helped him get through life’s pivots and challenges.
As a tribute to Memorial Sloan Kettering Board member Josephine “Josie” Robertson, Memorial Sloan Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.
Investigators have employed mutant mice to study how the accumulation of genetic errors is managed during egg and sperm formation.